Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Adrenergic Agonists: Indirect-Acting Agents01:25

Adrenergic Agonists: Indirect-Acting Agents

2.3K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
2.3K
Stimulants01:29

Stimulants

595
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
595
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

2.6K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
2.6K
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

1.3K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.3K
Experimental Designs01:16

Experimental Designs

16.2K
An experimental design is a systematic process that allows researchers to evaluate the relationship between dependent and independent variables. There are three widely used types of experimental design - pre-experimental design, true experimental design, and quasi-experimental design. In pre-experimental design, the researcher compares the data before and after some interventions or treatments. The true-experimental design has more than one purposefully created group, a commonly measured...
16.2K
Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants

1.8K

Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.8K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Triazole 187 is a biased KOR agonist that suppresses itch without sedation and induces anxiolytic-like behaviors in mice.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2026
Same author

Characterization of the GTPγS release function of a G protein-coupled receptor.

Nature communications·2025
Same author

GTP release-selective agonists prolong opioid analgesic efficacy.

Nature·2025
Same author

Exceptionally Potent Chiral Anandamide Analogs.

Journal of medicinal chemistry·2025
Same author

Bidirectional Modification of a <i>Galbulimima</i> Alkaloid Identifies Selective Opioid Ligands.

ACS central science·2025
Same author

Crystal structures of agonist-bound human cannabinoid receptor CB<sub>1</sub>.

Nature·2025

関連する実験動画

Updated: Nov 10, 2025

Caffeine Extraction, Enzymatic Activity and Gene Expression of Caffeine Synthase from Plant Cell Suspensions
09:11

Caffeine Extraction, Enzymatic Activity and Gene Expression of Caffeine Synthase from Plant Cell Suspensions

Published on: October 2, 2018

13.0K

カフェインなしか普通? カフェイン受容体を活性化する

Edward L Stahl1, Laura M Bohn1

  • 1The Scripps Research Institute, Department of Molecular Medicine, Jupiter, FL 33458, USA.

Cell
|April 2, 2021
PubMed
まとめ
この要約は機械生成です。

部分的アゴニストは,システムと比較薬に依存する薬効性があります. この研究では,Gタンパク質結合受容体 (GPCR) 部分アゴニストの内在的有効性を直接測定するために生体物理的方法を使用しました.

さらに関連する動画

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
11:00

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes

Published on: September 18, 2017

10.4K
Experimental Protocol for Examining Behavioral Response Profiles in Larval Fish: Application to the Neuro-stimulant Caffeine
08:33

Experimental Protocol for Examining Behavioral Response Profiles in Larval Fish: Application to the Neuro-stimulant Caffeine

Published on: July 24, 2018

11.5K

関連する実験動画

Last Updated: Nov 10, 2025

Caffeine Extraction, Enzymatic Activity and Gene Expression of Caffeine Synthase from Plant Cell Suspensions
09:11

Caffeine Extraction, Enzymatic Activity and Gene Expression of Caffeine Synthase from Plant Cell Suspensions

Published on: October 2, 2018

13.0K
Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
11:00

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes

Published on: September 18, 2017

10.4K
Experimental Protocol for Examining Behavioral Response Profiles in Larval Fish: Application to the Neuro-stimulant Caffeine
08:33

Experimental Protocol for Examining Behavioral Response Profiles in Larval Fish: Application to the Neuro-stimulant Caffeine

Published on: July 24, 2018

11.5K

科学分野:

  • 薬理学について
  • バイオ物理学
  • 分子生物学

背景:

  • 部分的アゴニズムは,薬理学の重要な概念であり,最大応答に対する薬剤の有効性を定義する.
  • 部分的アゴニストの内在的な有効性はシステムおよび比較器に依存し,その特徴を複雑にします.
  • Gタンパク質結合受容体 (GPCR) は重要な薬物の標的であり,薬剤開発には部分的アゴニスト活性を理解することが不可欠である.

研究 の 目的:

  • GPCR部分アゴニストのシグネチャーを定義するための生体物理学的アプローチを開発し,適用する.
  • これらの化合物の固有の効能の変動を直接,定量的に測定する.
  • 分子レベルで部分的アゴニズムの生体物理的基礎を解明する.

主な方法:

  • GPCR-リガンドの相互作用を分析するために,高度な生体物理学技術を活用した.
  • 本質的な有効性を直接測定する方法を開発した.
  • 特定のGPCR部分アゴニストを特徴付けるためにこれらの方法を適用した.

主要な成果:

  • GPCRの部分的アゴニストの生理学的なシグネチャーを成功裏に定義しました.
  • 本質的な有効性の直接的な定量的な測定が提供され,有意な変動が明らかになった.
  • 部分的アゴニスト特性を区別する際に生体物理学的アプローチの有用性を実証した.

結論:

  • 生体物理的な方法は,GPCRの部分的アゴニストを特徴づける強力な方法を提供します.
  • 薬剤の効能を直接測定することで 薬剤の作用に関する重要な洞察が得られます
  • この研究は,薬剤設計における部分的アゴニズムとその影響の理解を進める.